Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/21/suppl_5/v184/481702/mdq185.pdf
Reference13 articles.
1. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours;Barnes,2005
2. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer;Bernier;N Engl J Med,2004
3. Radiotherapy plus cetuximab for locoregionally advanced squamous cell head and neck cancer: 5-year survival data from a phase III randomised trial, and relation between cetuximab-induced rash and survival;Bonner;Lancet Oncol,2010
4. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck;Cooper;N Engl J Med,2004
5. GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5, version 2.0;Ferlay,2004
Cited by 494 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic role of PD-L1 expression in head and neck squamous cell carcinoma: An institutional experience from India;Pathology - Research and Practice;2024-02
2. Treatment planning comparison for head and neck cancer between photon, proton, and combined proton–photon therapy – From a fixed beam line to an arc;Radiotherapy and Oncology;2024-01
3. Side effects of different head and neck radiotherapy doses on wistar rat’s behavior;Brain Research;2024-01
4. Head and neck malignant lymphoma and squamous cell carcinoma discernment, is DWI conclusive?;Egyptian Journal of Radiology and Nuclear Medicine;2023-12-11
5. Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol;PLOS ONE;2023-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3